Valion Bio, Inc. SEC filings VBIO
Valion Bio, Inc. has 402 filings in SEC EDGAR's recent list, going back to Sep 10, 2019. Its latest annual report, Form ARS, was filed on Apr 30, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 14, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Nov 2, 2026 (officer or director change, other events). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Officer or director change, Other events
|
Nov 2, 2026 | Oct 27, 2026 |
| 8-K |
Current report
Other events
|
Oct 29, 2026 | Oct 28, 2026 |
| 8-K |
Current report
Material agreement, Unregistered share sale
|
Oct 27, 2026 | Oct 26, 2026 |
| 8-K |
Current report
Other events
|
Oct 26, 2026 | Oct 26, 2026 |
| 8-K |
Current report
Other events
|
Oct 22, 2026 | Oct 21, 2026 |
| 424B3 | Prospectus | Oct 21, 2026 | — |
| EFFECT | Filing | Oct 20, 2026 | — |
| EFFECT | Filing | Oct 20, 2026 | — |
| S-3 | Shelf registration | Oct 16, 2026 | — |
| DEF 14A | Proxy statement | Oct 16, 2026 | Nov 12, 2026 |
| 8-K |
Current report
Other events
|
Oct 15, 2026 | Oct 15, 2026 |
| 8-K |
Current report
Other events
|
Oct 14, 2026 | Oct 14, 2026 |
| 8-K |
Current report
Material agreement, Unregistered share sale
|
Oct 8, 2026 | Oct 7, 2026 |
| S-3 | Shelf registration | Oct 8, 2026 | — |
| 8-K |
Current report
Other events
|
Oct 6, 2026 | Oct 5, 2026 |
| DRS | Filing | Oct 5, 2026 | — |
| PRE 14A | Preliminary proxy statement | Oct 2, 2026 | Oct 2, 2026 |
| 8-K |
Current report
Other events
|
Oct 1, 2026 | Sep 30, 2026 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Sep 23, 2026 | Sep 17, 2026 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Officer or director change, Regulation FD disclosure
|
Sep 1, 2026 | Aug 27, 2026 |
| 8-K |
Current report
Change to shareholder rights, Bylaw or fiscal year change, Regulation FD disclosure
|
Aug 27, 2026 | Aug 26, 2026 |
| RW | Registration withdrawal request | Aug 24, 2026 | — |
| 8-K/A |
Amended current report
Shareholder vote results
|
Aug 20, 2026 | Aug 14, 2026 |
| 8-K |
Current report
Unregistered share sale, Officer or director change, Shareholder vote results, Other events
|
Aug 17, 2026 | Aug 14, 2026 |
| 10-Q | Quarterly report | Aug 14, 2026 | Jun 30, 2026 |
| EFFECT | Filing | Aug 12, 2026 | — |
| 8-K |
Current report
Material agreement, Unregistered share sale, Other events
|
Aug 6, 2026 | Jul 31, 2026 |
| DEF 14A | Proxy statement | Jul 17, 2026 | Aug 14, 2026 |
| S-1 | Registration statement | Jul 17, 2026 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Jul 14, 2026 | Jul 14, 2026 |
| PRE 14A | Preliminary proxy statement | Jul 7, 2026 | Aug 14, 2026 |
| 8-K |
Current report
Unregistered share sale, Other events
|
Jun 18, 2026 | Jun 17, 2026 |
| S-8 | Employee stock plan registration | Jun 5, 2026 | — |
| S-8 | Employee stock plan registration | Jun 5, 2026 | — |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
Jun 3, 2026 | May 28, 2026 |
| 10-Q | Quarterly report | May 14, 2026 | Mar 31, 2026 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
May 14, 2026 | May 14, 2026 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
May 4, 2026 | May 1, 2026 |
| ARS | Annual report to shareholders | Apr 30, 2026 | Dec 31, 2025 |
| DEF 14A | Proxy statement | Apr 30, 2026 | May 28, 2026 |
| 8-K |
Current report
Bylaw or fiscal year change
|
Apr 23, 2026 | Apr 22, 2026 |
| PRE 14A | Preliminary proxy statement | Apr 20, 2026 | Apr 17, 2026 |
| EFFECT | Filing | Apr 15, 2026 | — |
| 424B3 | Prospectus | Apr 15, 2026 | — |
| CORRESP | Letter to the SEC | Apr 13, 2026 | — |
| DRS | Filing | Apr 13, 2026 | — |
| S-1 | Registration statement | Apr 13, 2026 | — |
| UPLOAD | Letter from the SEC | Apr 9, 2026 | — |
| DRS | Filing | Apr 6, 2026 | — |
| 10-K | Annual report | Mar 30, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Mar 25, 2026 | Mar 25, 2026 |
| 8-K |
Current report
Listing notice
|
Mar 20, 2026 | Mar 19, 2026 |
| 8-K |
Current report
Material agreement
|
Mar 13, 2026 | Mar 9, 2026 |
| 8-K |
Current report
Shareholder vote results, Other events
|
Mar 11, 2026 | Mar 11, 2026 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Mar 4, 2026 | Mar 2, 2026 |
| 8-K/A | Amended current report | Feb 23, 2026 | Dec 9, 2025 |
| DEFA14A | Additional proxy material | Feb 9, 2026 | — |
| 8-K |
Current report
Material agreement, Unregistered share sale
|
Feb 9, 2026 | Feb 6, 2026 |
| 424B3 | Prospectus | Jan 20, 2026 | — |
| 424B3 | Prospectus | Jan 20, 2026 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 20, 2026 | Jan 20, 2026 |
| EFFECT | Filing | Jan 16, 2026 | — |
| EFFECT | Filing | Jan 16, 2026 | — |
| CORRESP | Letter to the SEC | Jan 14, 2026 | — |
| CORRESP | Letter to the SEC | Jan 14, 2026 | — |
| DEF 14A | Proxy statement | Jan 9, 2026 | Jan 9, 2026 |
| UPLOAD | Letter from the SEC | Jan 5, 2026 | — |
| UPLOAD | Letter from the SEC | Jan 5, 2026 | — |
| D | Filing | Dec 29, 2025 | — |
| D | Filing | Dec 29, 2025 | — |
| PRE 14A | Preliminary proxy statement | Dec 29, 2025 | Dec 29, 2025 |
| S-3 | Shelf registration | Dec 29, 2025 | — |
| S-3 | Shelf registration | Dec 29, 2025 | — |
| 424B3 | Prospectus | Dec 12, 2025 | — |
| 424B3 | Prospectus | Dec 12, 2025 | — |
| 8-K |
Current report
Material agreement, Agreement ended, Acquisition or sale of assets, New debt, Unregistered share sale, Change to shareholder rights, Bylaw or fiscal year change, Regulation FD disclosure
|
Dec 11, 2025 | Dec 9, 2025 |
| 8-K |
Current report
Other events
|
Nov 18, 2025 | Nov 18, 2025 |
| 10-Q | Quarterly report | Nov 14, 2025 | Sep 30, 2025 |
| 8-K |
Current report
Results of operations, Exit or restructuring costs, Regulation FD disclosure
|
Nov 14, 2025 | Nov 12, 2025 |
| 8-K |
Current report
Other events
|
Nov 13, 2025 | Nov 13, 2025 |
| 424B3 | Prospectus | Nov 6, 2025 | — |
| S-3 | Shelf registration | Oct 17, 2025 | — |
| 8-K |
Current report
Officer or director change
|
Oct 15, 2025 | Oct 8, 2025 |
| 1-A-W | Offering statement withdrawal | Sep 17, 2025 | — |
| EFFECT | Filing | Sep 5, 2025 | — |
| 424B3 | Prospectus | Sep 5, 2025 | — |
| CORRESP | Letter to the SEC | Sep 3, 2025 | — |
| UPLOAD | Letter from the SEC | Sep 3, 2025 | — |
| S-3 | Shelf registration | Aug 29, 2025 | — |
| 8-K |
Current report
Other events
|
Aug 27, 2025 | Aug 27, 2025 |
| 8-K |
Current report
Other events
|
Aug 20, 2025 | Aug 20, 2025 |
| 10-Q | Quarterly report | Aug 14, 2025 | Jun 30, 2025 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Aug 14, 2025 | Aug 14, 2025 |
| EFFECT | Filing | Aug 12, 2025 | — |
| EFFECT | Filing | Aug 12, 2025 | — |
| 424B3 | Prospectus | Aug 12, 2025 | — |
| 424B3 | Prospectus | Aug 12, 2025 | — |
| CORRESP | Letter to the SEC | Aug 8, 2025 | — |
| CORRESP | Letter to the SEC | Aug 8, 2025 | — |
| S-3 | Shelf registration | Aug 8, 2025 | — |
| S-3 | Shelf registration | Aug 8, 2025 | — |
| UPLOAD | Letter from the SEC | Aug 5, 2025 | — |
| DRS | Filing | Aug 4, 2025 | — |
| DRSLTR | Filing | Aug 4, 2025 | — |
| UPLOAD | Letter from the SEC | Jul 31, 2025 | — |
| EFFECT | Filing | Jul 30, 2025 | — |
| 424B3 | Prospectus | Jul 30, 2025 | — |
| CORRESP | Letter to the SEC | Jul 28, 2025 | — |
| CORRESP | Letter to the SEC | Jul 25, 2025 | — |
| S-1/A | Amended registration statement | Jul 25, 2025 | — |
| S-8 | Employee stock plan registration | Jul 25, 2025 | — |
| S-8 | Employee stock plan registration | Jul 25, 2025 | — |
| DRS | Filing | Jul 25, 2025 | — |
| 8-K/A |
Amended current report
Material agreement
|
Jul 25, 2025 | Jun 18, 2025 |
| UPLOAD | Letter from the SEC | Jul 9, 2025 | — |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
Jul 7, 2025 | Jun 30, 2025 |
| CORRESP | Letter to the SEC | Jun 26, 2025 | — |
| 8-K |
Current report
Material agreement
|
Jun 25, 2025 | Jun 18, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Jun 25, 2025 | Jun 25, 2025 |
| UPLOAD | Letter from the SEC | Jun 17, 2025 | — |
| CORRESP | Letter to the SEC | Jun 6, 2025 | — |
| S-1 | Registration statement | Jun 6, 2025 | — |
| ARS | Annual report to shareholders | Jun 2, 2025 | Dec 31, 2024 |
| DEF 14A | Proxy statement | Jun 2, 2025 | Jun 30, 2025 |
| PRE 14A | Preliminary proxy statement | May 23, 2025 | Jun 30, 2015 |
| 8-K |
Current report
Regulation FD disclosure
|
May 22, 2025 | May 22, 2025 |
| UPLOAD | Letter from the SEC | May 21, 2025 | — |
| 8-K |
Current report
Other events
|
May 20, 2025 | May 20, 2025 |
| DRS | Filing | May 15, 2025 | — |
| DRSLTR | Filing | May 15, 2025 | — |
| 10-Q | Quarterly report | May 15, 2025 | Mar 31, 2025 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
May 15, 2025 | May 15, 2025 |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
May 14, 2025 | May 9, 2025 |
| EFFECT | Filing | May 13, 2025 | — |
| 424B3 | Prospectus | May 13, 2025 | — |
| CORRESP | Letter to the SEC | May 9, 2025 | — |
| S-1 | Registration statement | May 9, 2025 | — |
| UPLOAD | Letter from the SEC | May 8, 2025 | — |
| DRS | Filing | May 2, 2025 | — |
| DRSLTR | Filing | May 2, 2025 | — |
| 8-K |
Current report
Material agreement, Unregistered share sale, Change to shareholder rights, Bylaw or fiscal year change
|
May 2, 2025 | Apr 29, 2025 |
| 8-K |
Current report
Other events
|
Apr 22, 2025 | Apr 22, 2025 |
| 8-K |
Current report
Other events
|
Apr 14, 2025 | Apr 14, 2025 |
| 424B5 | Prospectus supplement | Apr 14, 2025 | — |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Apr 10, 2025 | Apr 4, 2025 |
| 8-K |
Current report
Unregistered share sale, Other events
|
Apr 3, 2025 | Mar 28, 2025 |
| 10-K | Annual report | Mar 21, 2025 | Dec 31, 2024 |
| 8-K |
Current report
Material agreement, Results of operations, Unregistered share sale, Regulation FD disclosure
|
Mar 21, 2025 | Mar 18, 2025 |
| 8-K |
Current report
Other events
|
Mar 6, 2025 | Mar 6, 2025 |
| 8-K |
Current report
Change to shareholder rights, Bylaw or fiscal year change, Regulation FD disclosure
|
Mar 5, 2025 | Mar 4, 2025 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Feb 24, 2025 | Feb 18, 2025 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Bylaw or fiscal year change, Regulation FD disclosure
|
Feb 12, 2025 | Feb 10, 2025 |
| 8-K |
Current report
Shareholder vote results
|
Feb 5, 2025 | Jan 31, 2025 |
| DEF 14A | Proxy statement | Jan 3, 2025 | Jan 31, 2025 |
| 8-K |
Current report
Listing notice
|
Jan 3, 2025 | Dec 27, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Dec 23, 2024 | Dec 23, 2024 |
| PRE 14A | Preliminary proxy statement | Dec 23, 2024 | Jan 31, 2025 |
| 1-A/A | Filing | Dec 13, 2024 | — |
| 10-Q | Quarterly report | Nov 14, 2024 | Sep 30, 2024 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Nov 14, 2024 | Nov 14, 2024 |
| 1-A/A | Filing | Nov 7, 2024 | — |
| 1-A/A | Filing | Oct 4, 2024 | — |
| 8-K |
Current report
Other events
|
Sep 18, 2024 | Sep 18, 2024 |
| 8-K |
Current report
Other events
|
Sep 17, 2024 | Sep 17, 2024 |
| 8-K |
Current report
Material agreement, Officer or director change, Regulation FD disclosure
|
Sep 13, 2024 | Sep 12, 2024 |
| 424B5 | Prospectus supplement | Sep 13, 2024 | — |
| 1-A | Filing | Aug 16, 2024 | — |
| 10-Q | Quarterly report | Aug 14, 2024 | Jun 30, 2024 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Aug 14, 2024 | Aug 14, 2024 |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
Aug 13, 2024 | Aug 9, 2024 |
| 8-K |
Current report
Agreement ended
|
Aug 2, 2024 | Aug 1, 2024 |
| 8-K |
Current report
Listing notice
|
Jul 3, 2024 | Jun 28, 2024 |
| DEFA14A | Additional proxy material | Jun 28, 2024 | — |
| ARS | Annual report to shareholders | Jun 28, 2024 | Dec 31, 2023 |
| DEF 14A | Proxy statement | Jun 28, 2024 | Jun 28, 2024 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Jun 18, 2024 | Jun 17, 2024 |
| 8-K |
Current report
Material agreement, Agreement ended
|
May 30, 2024 | May 24, 2024 |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
May 22, 2024 | May 17, 2024 |
| 10-Q | Quarterly report | May 15, 2024 | Mar 31, 2024 |
| 8-K |
Current report
Acquisition or sale of assets, Regulation FD disclosure
|
May 15, 2024 | May 15, 2024 |
| 8-K |
Current report
Material agreement, Other events
|
May 13, 2024 | May 9, 2024 |
| 424B4 | Prospectus | May 13, 2024 | — |
| EFFECT | Filing | May 9, 2024 | — |
| CORRESP | Letter to the SEC | May 8, 2024 | — |
| CORRESP | Letter to the SEC | May 8, 2024 | — |
| 8-K |
Current report
Other events
|
May 8, 2024 | May 8, 2024 |
| S-1/A | Amended registration statement | May 8, 2024 | — |
| S-1/A | Amended registration statement | Apr 29, 2024 | — |
| UPLOAD | Letter from the SEC | Apr 8, 2024 | — |
| S-1 | Registration statement | Mar 29, 2024 | — |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Mar 25, 2024 | Mar 25, 2024 |
| 10-K | Annual report | Mar 25, 2024 | Dec 31, 2023 |
| 8-K |
Current report
Agreement ended, Officer or director change
|
Jan 26, 2024 | Jan 22, 2024 |
| 10-Q | Quarterly report | Nov 14, 2023 | Sep 30, 2023 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Nov 14, 2023 | Nov 14, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Sep 26, 2023 | Sep 26, 2023 |
| 8-K |
Current report
Listing notice, Regulation FD disclosure
|
Sep 20, 2023 | Sep 15, 2023 |
| 8-K |
Current report
Change to shareholder rights, Bylaw or fiscal year change, Regulation FD disclosure
|
Aug 22, 2023 | Aug 21, 2023 |
| 10-Q | Quarterly report | Aug 14, 2023 | Jun 30, 2023 |
| 8-K |
Current report
Results of operations, Shareholder vote results, Regulation FD disclosure
|
Aug 14, 2023 | Aug 11, 2023 |
Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- VBIO (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- San Antonio, TX
- SEC filer status
- , Emerging growth company
- SEC CIK
- 1787740
- Former names
- Tivic Health Systems, Inc. (until Apr 23, 2026)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.